Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study

(MedPage Today) — PHOENIX — Use of tirzepatide (Mounjaro, Zepbound) was associated with significantly lower risks of death, hospitalization, and major cardiovascular events compared with semaglutide (Ozempic, Wegovy) in high-risk patients with…

Source link : https://www.medpagetoday.com/meetingcoverage/acg/118194

Author :

Publish date : 2025-10-28 21:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Dual GIP/GLP-1 Drug Linked to Fewer Deaths in Real-World Liver Disease Study

Quantum-inspired algorithm could help reveal hidden cosmic objects

Difficult-to-Treat Rheumatoid Arthritis: Is Prevention Feasible?

Related Posts

Simple Strategy Can Slash ED Use in Older Cancer Patients

Oral Anticoagulants Raise Abnormal Uterine Bleeding Risk

Do Food Allergies Affect Growth Patterns in Children?

Ethosuximide Shows No Significant Benefit for IBS Pain

Safe spaces needed for drug-addicted children, say grieving mums

The curious question of whether gut health affects ageing

Simple Strategy Can Slash ED Use in Older Cancer Patients

Oral Anticoagulants Raise Abnormal Uterine Bleeding Risk

Do Food Allergies Affect Growth Patterns in Children?

Ethosuximide Shows No Significant Benefit for IBS Pain

Safe spaces needed for drug-addicted children, say grieving mums

The curious question of whether gut health affects ageing

How Often Do Physicians Encounter ‘Difficult’ Patients?

Regimen Improves PFS in Highly Mutated Metastatic Colorectal Cancer

Categories

Archives